FDA.reportPublic FDA data

laronidase 2.9 MG in 5 ML Injection

RxCUI
403822
RxNorm name
laronidase 2.9 MG in 5 ML Injection
Display name
laronidase 2.9 MG in 5 ML Injection
Full name
laronidase 2.9 MG in 5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125058Aldurazymelaronidase351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a80ac249-cae4-41f3-88bb-344088b20e60laronidase 2.9 MG in 5 ML Injection [PSN] · 5 ML laronidase 0.58 MG/ML Injection [SCD] · laronidase 2.9 MG per 5 ML Injection [SY]337These highlights do not include all the information needed to use ALDURAZYME safely and effectively. See full prescribing information for ALDURAZYME. ALDURAZYME (laronidase) injection, for intravenous use Initial U.S. Approval: 200320231222